Skip to main content

Licensing Opportunities available from Warwick Ventures

biology logo Chemistry logo Computing logo Engineering logo Medicine logo Physics logo
Biology Chemistry Computing Engineering Medicine Physics

These pages contain details of the technologies currently available to licence from Warwick Ventures.
If you would like more details of any of these technologies, please contact the relevant Business Development
Manager.

New technologies are added regularly, so do please register your interest and we will send through details of
opportunities as they are published. You can also use the RSS feed on the Licensing Opportunities page to
keep up to date.


A Novel Ammonia Synthesis Catalyst Promoter for the Haber-Bosch Process

A University of Warwick team, led by Professor Shanwen Tao, has available for license intellectual property, a novel catalyst promoter for improving the efficiency of ammonia synthesis using the Haber-Bosch process.

More details: A Novel Ammonia Synthesis Catalyst - Licensing Opportunity

Contact: Dr James Lapworth, Business Development Manager, Warwick Ventures. Tel: +44 (0) 2476 575 481; email: j.lapworth@warwick.ac.uk

Wed 01 August 2018, 16:00

Improvements to electrospray ionisation

A University of Warwick team, led by Professor Pete O’Connor, has available for licence intellectual property using CI to increase the average charge state of ions generated by electrospray ionisation.

More details: Improvements to eletrospray ionisation

Contact: Dr Shum Prakash, Business Development Manager, Warwick Ventures. Tel: +44 (0) 24 7657 4145; email:s.prakash@warwick.ac.uk

Tue 04 October 2016, 13:23 | Tags: Chemistry

Two-dimensional mass spectrometry in any inexpensive linear ion trap

A University of Warwick team, led by Professor Pete O’Connor, has available for licence intellectual property relating to a method of two dimensional mass spectrometry, to be utilised in any mass spectrometer containing a linear ion trap.

More details: Two-dimensional mass spectrometry in any inexpensive linear ion trap

Contact: Dr Shum Prakash, Business Development Manager, Warwick Ventures. Tel: +44 (0) 24 7657 4145; email:s.prakash@warwick.ac.uk

Tue 04 October 2016, 12:51 | Tags: Chemistry

IVF pre-implantation screening method

image

A team at the University of Warwick has developed a new screening test that potentially provides an accurate and noninvasive method for assessing embryos during IVF treatment, prior to implantation.

More details: IVF pre-implantation screening method

Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk

Thu 17 December 2015, 11:38 | Tags: Life Sciences and Biotechnology

Increased Epigenetic Variation in Plants

image

A team at the University of Warwick has developed technology to increase the epigenetic variety of plants without the usual undesired side effects. The novel strategy allows a much greater range of epigenetic and phenotypic differences to be introduced than was previously possible.

More details: Increased epigenetic variation in plants

Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk

Mon 23 November 2015, 16:02 | Tags: Life Sciences and Biotechnology

New Test to Accurately Determine the Onset of Labour

image

A team at the University of Warwick has developed a new test that provides an accurate way to confirm the onset of labour in both full term and preterm pregnancies. A second application for the test is expected to be the identification of women who may not progress during induction.

More details: A new test to accurately determine the onset of labour

Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk

Mon 23 November 2015, 15:01 | Tags: Medicine and Pharmaceuticals

A novel target and therapeutic leads for the treatment of bovine and human RSV

image

Warwick Ventures has available for licence a patent application covering an entirely novel conserved host cell protein target for the treatment of bovine and human RSV. Promising proof-of-concept studies have demonstrated significant anti-viral activity with a number of chemical lead compounds which are suitable for entry into a drug discovery program.

More details: A novel target and therapeutic leads for the treatment of bovine and human RSV

Contact: Andrew Lee, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75745; email: L.Lane@warwick.ac.uk

Tue 22 July 2014, 15:39 | Tags: Life Sciences and Biotechnology

Novel Cryopreservation Technique

image

Warwick Ventures has available for licence a novel cryopreservation technique, without the need for vitrification, resulting in enhanced cell preservation and reduction of cell damage. This technology has many applications, but is particularly suited to the preservation of cell lines or blood for transfusion. This technology would be of interest to companies involved in sample handling and storage, or organisations involved in the collection and storage of cellular materials.

More details: Novel Cryopreservation Technique

Contact: Laura Lane, Business Development Associate, Warwick Ventures. Tel: (0)24 765 75745
Email: l.lane@warwick.ac.uk

 

Thu 22 August 2013, 15:11 | Tags: Chemistry